Alpha-1-antitrypsin improves anastomotic healing in intestinal epithelial cells model
Topic overview
This in vitro study demonstrates that alpha-1-antitrypsin (AAT) at physiological concentrations significantly accelerates intestinal epithelial cell wound closure and proliferation, suggesting potential therapeutic application for preventing anastomotic leakage in pediatric intestinal surgery.
Key takeaways
- Alpha-1-antitrypsin (AAT) at physiological concentrations (1 mg/ml) accelerates intestinal epithelial wound closure by 2-fold compared to controls.
- AAT treatment significantly increases expression of proliferation genes (CDKN1A, CDKN2A, WNT3, COL3A1) in intestinal epithelial cells.
- Local AAT administration shows therapeutic potential to reduce anastomotic leak risk in pediatric intestinal surgery.
- AAT decreases IL-8 levels without affecting CXCL8 mRNA, suggesting anti-inflammatory effects during wound healing.
- In vitro model demonstrates 97% wound closure at 18 hours with AAT versus 60% in controls, supporting clinical translation studies.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Alpha-1-antitrypsin improves anastomotic healing in intestinal epithelial cells model. GlobalCastMD Medical Library. 2024-09-30. https://dev.library.globalcastmd.com/article/9220?via_space=staycurrentmd
Comments